Larvol Delta - Individualized-Holding-and-Bridging-Therapy-Achieves-High-Response-Rates-and-Reduces-Toxicity-of-BcmaDirected-CART-Cell-Therapy-in-Multiple-Myeloma

Carvykti (ciltacabtagene autoleucel) - J&J

Abecma (idecabtagene vicleucel) - BMS

https://imsannual2026.eventscribe.net/ajaxcalls/PosterInfo.asp?efp=TU1XRFNPTlIyMjY0Nw&PosterID=826812&rnd=0.1563022

Veena B. Krishnan, MD

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next